Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis

References

• Llovet JM. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):7. doi:10.1038/s41572-021-00245-6
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Brosh RM, Matson SW. History of DNA Helicases. Genes. 2020;11(3):255. doi:10.3390/genes11030255
   PubMed Web of Science ®Google Scholar
• von Felden J, Garcia-Lezana T, Schulze K, et al. Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut. 2020;69(11):2025–2034. doi:10.1136/gutjnl-2019-320282
   PubMed Web of Science ®Google Scholar
• Villanueva A, Longo DL. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Frenette C. Advances in hepatocellular carcinoma. Clin Liver Dis. 2020;24(4):xiii–xiv. doi:10.1016/j.cld.2020.08.014
   PubMed Web of Science ®Google Scholar
• Vyas M, Zhang X. Hepatocellular carcinoma: role of pathology in the era of precision medicine. Clin Liver Dis. 2020;24(4):591–610.
   PubMed Web of Science ®Google Scholar
• De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50(11):1115–1123.
   PubMedGoogle Scholar
• Wang X, Zhang A, Sun H. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology. 2013;57(5):2072–2077.
   PubMed Web of Science ®Google Scholar
• Dhar S, Datta A, Brosh RM. DNA helicases and their roles in cancer. DNA Repair (Amst). 2020;96:102994. doi:10.1016/j.dnarep.2020.102994
   PubMed Web of Science ®Google Scholar
• Abdelhaleem M. Helicases: an overview. Methods Mol Biol. 2010;587:1–12. doi:10.1007/978-1-60327-355-8_1
   PubMedGoogle Scholar
• Brosh RM. DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer. 2013;13(8):542–558. doi:10.1038/nrc3560
   PubMed Web of Science ®Google Scholar
• Gupta R, Brosh RM. DNA repair helicases as targets for anti-cancer therapy. Curr Med Chem. 2007;14(5):503–517. doi:10.2174/092986707780059706
   PubMed Web of Science ®Google Scholar
• Germain DR, Graham K, Glubrecht DD, et al. DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat. 2011;127(1):53–63. doi:10.1007/s10549-010-0943-7
   PubMed Web of Science ®Google Scholar
• Miao X, Yang Z-L, Xiong L, et al. Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Int J Clin Exp Pathol. 2013;6(2):179–190.
   PubMed Web of Science ®Google Scholar
• Heerma van Voss MR, Schrijver WA, ter Hoeve ND, et al. The prognostic effect of DDX3 upregulation in distant breast cancer metastases. Clin Exp Metastasis. 2017;34(1):85–92. doi:10.1007/s10585-016-9832-8
   PubMed Web of Science ®Google Scholar
• Kouyama Y, Masuda T, Fujii A, et al. Oncogenic splicing abnormalities induced by DEAD -Box Helicase 56 amplification in colorectal cancer. Cancer Sci. 2019;110(10):3132–3144. doi:10.1111/cas.14163
   PubMed Web of Science ®Google Scholar
• Zhu C, Zhang X, Kourkoumelis N, et al. Integrated analysis of DEAD-box helicase 56: a potential oncogene in osteosarcoma. Front Bioeng Biotechnol. 2020;8:588. doi:10.3389/fbioe.2020.00588
   PubMed Web of Science ®Google Scholar
• Wu Q, Luo X, Terp MG, et al. DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma. Mol Cancer. 2021;20(1):108. doi:10.1186/s12943-021-01403-w
   PubMed Web of Science ®Google Scholar
• Ma M, Dai J, Tang H, et al. MicroRNA-23a-3p inhibits mucosal melanoma growth and progression through targeting adenylate cyclase 1 and attenuating cAMP and MAPK pathways. Theranostics. 2019;9(4):945–960. doi:10.7150/thno.30516
   PubMed Web of Science ®Google Scholar
• Kawamura N, Takaoka K, Hamada H, et al. Rab7-mediated endocytosis establishes patterning of Wnt activity through inactivation of Dkk antagonism. Cell Rep. 2020;31(10):107733. doi:10.1016/j.celrep.2020.107733
   PubMed Web of Science ®Google Scholar
• Hirano S. Western blot analysis. Methods Mol Biol. 2012;926:87–97.
   PubMedGoogle Scholar
• Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173(2):530. doi:10.1016/j.cell.2018.03.059
   PubMed Web of Science ®Google Scholar
• Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.
   PubMedGoogle Scholar
• Sun BY, Zhou C, Guan R-Y, et al. Dissecting intra-tumoral changes following immune checkpoint blockades in intrahepatic cholangiocarcinoma via single-cell analysis. Front Immunol. 2022;13:871769. doi:10.3389/fimmu.2022.871769
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• The Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049–56. doi:10.1093/nar/gku1179
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27
   PubMed Web of Science ®Google Scholar
• Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019;14(2):482–517. doi:10.1038/s41596-018-0103-9
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Song WM, Zhang B. Multiscale embedded gene co-expression network analysis. PLoS Comput Biol. 2015;11(11):e1004574. doi:10.1371/journal.pcbi.1004574
   PubMed Web of Science ®Google Scholar
• Chen R, Zhao S, Tian Z, Ding BY. A multiscale clustering approach for non-IID nominal data. Comput Intell Neurosci. 2021;2021:8993543. doi:10.1155/2021/8993543
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• David CC, Jacobs DJ. Principal component analysis: a method for determining the essential dynamics of proteins. Methods Mol Biol. 2014;1084:193–226.
   PubMedGoogle Scholar
• Becht E, McInnes L, Healy J, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018. doi:10.1038/nbt.4314
   PubMed Web of Science ®Google Scholar
• McKusick VA. HUGO news. The Human Genome Organisation: history, purposes, and membership. Genomics. 1989;5(2):385–387. doi:10.1016/0888-7543(89)90077-3
   PubMed Web of Science ®Google Scholar
• Patel SS, Pandey M, Nandakumar D. Dynamic coupling between the motors of DNA replication: hexameric helicase, DNA polymerase, and primase. Curr Opin Chem Biol. 2011;15(5):595–605. doi:10.1016/j.cbpa.2011.08.003
   PubMed Web of Science ®Google Scholar
• Patel SS, Picha KM. Structure and function of hexameric helicases. Annu Rev Biochem. 2000;69(1):651–697. doi:10.1146/annurev.biochem.69.1.651
   PubMed Web of Science ®Google Scholar
• Sun B, Johnson DS, Patel G, et al. ATP-induced helicase slippage reveals highly coordinated subunits. Nature. 2011;478(7367):132–135. doi:10.1038/nature10409
   PubMed Web of Science ®Google Scholar
• Gangloff S, Soustelle C, Fabre F. Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases. Nat Genet. 2000;25(2):192–194. doi:10.1038/76055
   PubMed Web of Science ®Google Scholar
• Sun B, Wang MD. Single-molecule perspectives on helicase mechanisms and functions. Crit Rev Biochem Mol Biol. 2016;51(1):15–25. doi:10.3109/10409238.2015.1102195
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20. doi:10.1016/j.cmet.2007.10.002
   PubMed Web of Science ®Google Scholar
• Srinivas US, Tan BWQ, Vellayappan BA, et al. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. doi:10.1016/j.redox.2018.101084
   PubMed Web of Science ®Google Scholar
• Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481(7381):287–294. doi:10.1038/nature10760
   PubMed Web of Science ®Google Scholar
• Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer. 2012;12(12):801–817. doi:10.1038/nrc3399
   PubMed Web of Science ®Google Scholar
• Smith HL, Southgate H, Tweddle DA, et al. DNA damage checkpoint kinases in cancer. Expert Rev Mol Med. 2020;22:e2. doi:10.1017/erm.2020.3
   PubMed Web of Science ®Google Scholar
• Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008. doi:10.1101/cshperspect.a001008
   PubMed Web of Science ®Google Scholar
• Hussain SP, Schwank J, Staib F, et al. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26(15):2166–2176. doi:10.1038/sj.onc.1210279
   PubMed Web of Science ®Google Scholar
• Rath O, Kozielski F. Kinesins and cancer. Nat Rev Cancer. 2012;12(8):527–539. doi:10.1038/nrc3310
   PubMed Web of Science ®Google Scholar
• Lucanus AJ, Yip GW. Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics. Oncogene. 2018;37(7):833–838. doi:10.1038/onc.2017.406
   PubMed Web of Science ®Google Scholar
• Li Q, Qiu J, Yang H, et al. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. Cancer Lett. 2020;482:112–125. doi:10.1016/j.canlet.2019.11.008
   PubMed Web of Science ®Google Scholar
• Wei S, Dai M, Zhang C, et al. KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma. Protein Cell. 2021;12(10):788–809. doi:10.1007/s13238-020-00766-y
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shen M, Zhou G. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1. Biochem Biophys Res Commun. 2018;496(2):482–489. doi:10.1016/j.bbrc.2018.01.046
   PubMed Web of Science ®Google Scholar
• Bai L, Ren Y, Cui T. Overexpression of CDCA5, KIF4A, TPX2, and FOXM1 coregulated cell cycle and promoted hepatocellular carcinoma development. J Comput Biol. 2020;27(6):965–974. doi:10.1089/cmb.2019.0254
   PubMed Web of Science ®Google Scholar
• Li S, Wu L, Zhang H, et al. GINS1 induced sorafenib resistance by promoting cancer stem properties in human hepatocellular cancer cells. Front Cell Dev Biol. 2021;9:711894. doi:10.3389/fcell.2021.711894
   PubMed Web of Science ®Google Scholar
• Li M, Shi M, Hu C, et al. MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation. Oncogene. 2021;40(22):3870–3884. doi:10.1038/s41388-021-01816-3
   PubMed Web of Science ®Google Scholar
• Tang L, Yu W, Wang Y, et al. Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma. Clin Transl Oncol. 2019;21(12):1624–1633. doi:10.1007/s12094-019-02090-2
   PubMed Web of Science ®Google Scholar
• Wang T, Lu J, Wang R, et al. TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p. J Cancer. 2022;13(2):589–601. doi:10.7150/jca.64017
   PubMed Web of Science ®Google Scholar
• Wang X, Wang M, Li X-Y, et al. KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo. Oncol Lett. 2019;18(6):5739–5746. doi:10.3892/ol.2019.10985
   PubMed Web of Science ®Google Scholar
• Wang K, Li B, Fan P, et al. Downregulation of DEAD-box helicase 21 (DDX21) inhibits proliferation, cell cycle, and tumor growth in colorectal cancer via targeting cell division cycle 5-like (CDC5L). Bioengineered. 2021;12(2):12647–12658. doi:10.1080/21655979.2021.2011636
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang Y, Chen C, et al. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer. Cancer Lett. 2018;437:67–78. doi:10.1016/j.canlet.2018.08.021
   PubMed Web of Science ®Google Scholar
• Wang X, Wu Z, Qin W, et al. Long non-coding RNA ZFAS1 promotes colorectal cancer tumorigenesis and development through DDX21-POLR1B regulatory axis. Aging. 2020;12(22):22656–22687. doi:10.18632/aging.103875
   PubMedGoogle Scholar
• Lu P, Yu Z, Wang K, et al. DDX21 interacts with WDR5 to promote colorectal cancer cell proliferation by activating CDK1 expression. J Cancer. 2022;13(5):1530–1539. doi:10.7150/jca.69216
   PubMed Web of Science ®Google Scholar